Life Sciences
August 8, 2022
The Navy Yard Welcomes Vinta Bio
The Navy Yard is pleased to welcome Vinta Bio, our newest life sciences company, to the Navy Yard community located at 4050 S. 26th Street, Suite 200. Vinta Bio, a contract development and manufacturing organization (CDMO), is focused on helping customers develop and manufacture viral vectors and cell therapy products. Its vision is to grow
Read MoreDevelopment Updates
June 28, 2022
2022 Navy Yard Plan Unveiled
Media contacts:Jennifer Tran, PIDC, 215-218-2854Robbie Tarpley Raffish, a.s.a.p.r., 410-430-9705 Press Kit with Renderings Available at https://bit.ly/navyyardplanpressCREDIT: Renderings by James Corner Field Operations, courtesy of PIDC and Ensemble/Mosaic 2022 Navy Yard Plan Unveiled, Focused on Job Creation, Equitable Growth, & Increased Accessibility PIDC and Ensemble/Mosaic today unveiled the 2022 Navy Yard Plan, a transformative roadmap for equitable
Read MoreDevelopment Updates
June 21, 2022
Construction Update: 2500 League Island Boulevard
In fall 2021, Gattuso Development Partners broke ground on its newest construction project at the Navy Yard. 2500 League Island Boulevard is a premier Current Good Manufacturing Practice (cGMP) 130,000 square foot life science facility located at the corner of 26th & League Island Blvd West (formerly Langley Ave). The building is a ground up
Read MoreLife Sciences
April 20, 2022
Congresswoman Scanlon Delivers $525,000 for Innovative Workforce Program at the Navy Yard
On Friday, April 15, Congresswoman Mary Gay Scanlon (PA-05) joined officials from PIDC, the West Philadelphia Skills Initiative, and Philly Shipyard, Inc. to celebrate the latest graduates of the Navy Yard Skills Initiative and announce over half a million dollars in new federal funding to support the workforce program. Scanlon secured $525,000 for PIDC’s Navy
Read MoreDevelopment Updates
March 15, 2022
Ensemble/Mosaic and Oxford Properties Group Break Ground on Speculative R & D Lab Building
Ensemble/Mosaic, a joint venture between Ensemble Real Estate Investments and Mosaic Development Partners, and Oxford Properties Group (“Oxford”), a leading global real estate investor, asset manager and business builder, have broken ground on 1201 Normandy Place, a speculative 137,000 square foot R & D lab building at the Navy Yard in Philadelphia. The project represents
Read MoreDevelopment Updates
March 1, 2022
Oxford +Ensemble/Mosaic Partner to Create 3M SqFt Life Sciences Hub
Ensemble/Mosaic and Oxford Properties Group (“Oxford”) have entered into a strategic partnership which will, over time, own and develop up to 3 million square feet of life science properties at the Navy Yard in Philadelphia. The agreement includes Oxford’s investment in five existing life science assets owned by Ensemble Real Estate Investments, and Ensemble/Mosaic’s first
Read MoreDevelopment Updates
November 15, 2021
WuXi ATU Opens New Facility in Philadelphia, Tripling Testing Capacity to Support Global Customers
WuXi Advanced Therapies (WuXi ATU), a wholly owned subsidiary of WuXi AppTec, announced the official opening of its advanced therapies testing facility at 400 Rouse Boulevard in Philadelphia’s Navy Yard. The new facility, which includes 140,000 square feet laboratories, will further enhance the company’s Contract Testing, Development and Manufacturing Organization (CTDMO) business model by tripling the company’s previous
Read MoreLife Sciences
September 29, 2021
Iovance Biotherapeutics Celebrates Grand Opening of Iovance Cell Therapy Center (iCTC)
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies (tumor-infiltrating lymphocyte, TIL, and peripheral-blood lymphocyte, PBL), is celebrating the official opening of the Iovance Cell Therapy Center (iCTC). The iCTC, located at the Philadelphia Navy Yard, is the first centralized, scalable, state-of-the-art manufacturing facility dedicated to producing TIL cell therapies for patients with
Read MoreDevelopment Updates
April 7, 2021
James Corner Field Operations Selected to Head Philadelphia Navy Yard Master Plan Update Team
Multidisciplinary Team Includes 13 Subject Matter Expert Consultants; More Than 50% are Certified Minority- and Women-owned Business Enterprises PIDC, Philadelphia’s public-private economic development corporation and master developer of the Philadelphia Navy Yard, in partnership with Ensemble Real Estate Investments and Mosaic Development Partners (“Ensemble/Mosaic”), today announced the selection of James Corner Field Operations (“Field Operations”) to
Read MoreCommunity
July 29, 2020
PIDC Selects Navy Yard Development Partner
Renderings available HERE. PIDC, Philadelphia’s public-private economic development corporation, has selected a team comprised of Ensemble Real Estate Investments and Mosaic Development Partners as its development partner for 109 acres at the Philadelphia Navy Yard. Selection of the Ensemble/Mosaic team is the culmination of a year-long competitive process that attracted interest from more than 35
Read MoreCommunity
February 7, 2020
PIDC Announces a Navy Yard Leadership Transition
This week, PIDC President Anne Bovaird Nevins announced a Navy Yard leadership transition. Senior Vice President Prema Katari Gupta has accepted a new position at the Center City District and will leave PIDC after nearly five years of leading the Navy Yard team, and Kate McNamara, PIDC’s Vice President of Real Estate Services, has been
Read MoreAmenities
January 2, 2020
20 Navy Yard Businesses You Could Work For this Year!
As a historic, thriving waterfront district in Philadelphia, the Navy Yard is bustling with 15k people, 175 companies, and hundreds of career opportunities for all! Take a look at these 20 Navy Yard businesses that you could work for in 2020!
Read MoreDevelopment Updates
July 30, 2019
Construction Update: 400 Rouse Boulevard
The 95,000 square foot build-to-suit office and laboratory building for WuXi AppTec’s Advanced Therapies Business Unit (WuXi ATU), located at 400 Rouse Boulevard, is moving forward as expected.
Read MoreLife Sciences
May 29, 2019
Iovance Biotherapeutics Announces New Facility at the Navy Yard to Support U.S. Production of Tumor Infiltrating Lymphocyte Cell Therapy Products
Iovance Biotherapeutics, Inc., a late-stage biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, today announced that it has entered into a lease agreement to build an approximately 136,000 square foot commercial-scale production facility at the Philadelphia Navy Yard for commercial and clinical production of autologous TIL products, including its candidate lifileucel.
Read MoreAmenities
January 4, 2019
101 Ways Navy Yard Visitors Discovered the Yard in 2018!
From Sea Monsters to Naval Ships, Sunsets and Office Life, there is always something to discover at the Navy Yard. Check out 101 ways Navy Yard Visitors Discovered the Yard in 2018!
Read More